MRC Human Immunology Unit
We are a leading research centre in human immunology and the development of treatments against infectious diseases, cancer, allergy and autoimmune disease.
Chen Y-L. et al, (2020), J Exp Med, 217
A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
Powell TJ. et al, (2019), J Gen Virol, 100, 431 - 445
Maelfait J. et al, (2019), Journal of Molecular Biology
Self-maintaining CD103+ cancer-specific T cells are highly energetic with rapid cytotoxic and effector responses.
Abd Hamid M. et al, (2019), Cancer Immunol Res
Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans
RIJAL P. and TOWNSEND A., (2019), Journal of Virology